ASO Visual Abstract: Hepatectomy Following Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy in Patients with Unresectable Hepatocellular Carcinoma.
Ann Surg Oncol
; 30(5): 2791-2792, 2023 May.
Article
in En
| MEDLINE
| ID: mdl-36869918
Full text:
1
Database:
MEDLINE
Language:
En
Journal:
Ann Surg Oncol
Journal subject:
NEOPLASIAS
Year:
2023
Type:
Article
Affiliation country:
China